Project description
EU-Africa collaboration in fostering infectious disease drug discovery
Infectious diseases disproportionately burden Sub-Saharan Africa, which lacks a critical mass of appropriately skilled scientists, access to general infrastructure, enabling technology platforms, and expertise for drug discovery research. The EU-funded RAFIKI project will therefore strengthen early drug discovery capacity in Africa, focusing on infectious diseases like malaria and tuberculosis. It will establish training hubs in South, East, and West Africa to support early- and mid-career researchers through training visits, mentorships, workshops and online courses. The project will also facilitate knowledge sharing for compound library curation and improve data management using the collaborative drug discovery (CDD) vault. The consortium will engage with industry stakeholders and potential public and private funders to secure funding.
Objective
The RAFIKI consortium will support capacity building for early drug discovery in Africa with a focus on infectious diseases (e.g. malaria, tuberculosis). Sub-Saharan Africa is disproportionately burdened by such diseases yet lacks a critical mass of appropriately skilled scientists and access to general infrastructure, enabling technology platforms and expertise for drug discovery research. RAFIKI will leverage existing collaborations within the consortium to build the knowledge and technical capacities of research institutions across Africa. RAFIKI will establish regional training hubs in South, East and West Africa to support local capacity/skillset building for early-/mid-career researchers via bidirectional scientific training visits, mentorships, regional in-person workshops and online training courses. To establish the requisite infrastructure for future drug discovery R&I, knowledge and procedures will be shared for compound library curation at partner institutions (i.e. workflows, open database creation, library sharing capabilities), and data management capacities will be bolstered using the Collaborative Drug Discovery (CDD) Vault. To secure funding beyond the project lifetime, the consortium will liaise with relevant industrial actors and potential public/private funders.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health scienceshealth sciencesinfectious diseasesmalaria
- natural sciencescomputer and information sciencesdatabases
- medical and health sciencesclinical medicinepneumologytuberculosis
You need to log in or register to use this function
Keywords
Programme(s)
Funding Scheme
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinator
13125 Berlin
Germany